Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01832168 · ClinicalTrials.gov registry record · NA
Randomized Clinical Trial Using Amniotic Membrane in Robotic Assisted Laparoscopic Prostatectomy
A NA study, sponsored by MiMedx Group.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT01832168: Completed NA study, sponsored by MiMedx Group.
NCT01832168 is a NA study that has completed, run by MiMedx Group. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01832168, a NA study, has completed, sponsored by MiMedx Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the AmnioFix dehydrated human amniotic membrane is effective in protecting nerves in men receiving robotic assisted laparoscopic prostatectomies.
Interventions
- PROCEDURE Robotic Assisted Laparoscopic Prostatectomy
- OTHER Application of Absorbable Hemostat
- OTHER Application of dehydrated human amniotic membrane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2013-02 |
| Est. Completion | 2014-06 |
| Phase | NA |
What the finished NCT01832168 record still lists
NCT01832168 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Robotic Assisted Laparoscopic Prostatectomy is the first listed.
NCT01832168 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01832168 about?
NCT01832168 is a clinical study titled "Randomized Clinical Trial Using Amniotic Membrane in Robotic Assisted Laparoscopic Prostatectomy". The purpose of this study is to determine whether the AmnioFix dehydrated human amniotic membrane is effective in protecting nerves in men receiving robotic assisted laparoscopic prostatectomies.
What is the current status of trial NCT01832168?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2013-02. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01832168?
The interventions under investigation include: Robotic Assisted Laparoscopic Prostatectomy (PROCEDURE), Application of Absorbable Hemostat (OTHER), Application of dehydrated human amniotic membrane (OTHER).
Who is sponsoring clinical trial NCT01832168?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01832168's enrollment target sits among peer trials
34 1570th of 2000 higher than 427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia